Cargando…

Tissue Damage in Human Cutaneous Leishmaniasis: Correlations Between Inflammatory Cells and Molecule Expression

Cutaneous leishmaniasis (CL) is caused by the bite of the infected sand fly, which inoculates parasites of Leishmania spp and triggers an immune response. An exacerbated cutaneous inflammatory response is crucial for controlling parasite burden but can also promote tissue damage. This study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saldanha, Maíra Garcia, Pagliari, Carla, Queiroz, Adriano, Machado, Paulo Roberto Lima, Carvalho, Lucas, Scott, Phillip, Carvalho, Edgar M., Arruda, Sérgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381142/ https://www.ncbi.nlm.nih.gov/pubmed/32766167 http://dx.doi.org/10.3389/fcimb.2020.00355

Ejemplares similares

Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis
por: Saldanha, Maíra G., et al.
Publicado: (2017)

Leishmania braziliensis Infection Enhances Toll-Like Receptors 2 and 4 Expression and Triggers TNF-α and IL-10 Production in Human Cutaneous Leishmaniasis
por: Polari, Ludmila P., et al.
Publicado: (2019)

High Anti-Leishmania IgG Antibody Levels Are Associated With Severity of Mucosal Leishmaniasis
por: de Lima, Clara Mônica F., et al.
Publicado: (2021)

The Influence of Infection by Different Leishmania (Viannia) braziliensis Isolates on the Pathogenesis of Disseminated Leishmaniasis
por: Oliveira, Walker N., et al.
Publicado: (2021)

Comparative analysis of the tissue inflammatory response in human cutaneous and disseminated leishmaniasis
por: Dantas, Marina Loyola, et al.
Publicado: (2014)

Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control
por: Noronha, Letícia Paula Trajano, et al.
Publicado: (2023)

Biomarkers of Cutaneous Leishmaniasis
por: Bahrami, Fariborz, et al.
Publicado: (2018)

Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms
por: Rizk, Yasmin Silva, et al.
Publicado: (2021)

Pioglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Downregulates the Inflammatory Response in Cutaneous Leishmaniasis Patients Without Interfering in Leishmania braziliensis Killing by Monocytes
por: Nascimento, Maurício T., et al.
Publicado: (2022)

Diabetes Modifies the Clinic Presentation of Cutaneous Leishmaniasis
por: Lago, Alexsandro S, et al.
Publicado: (2020)

Plantar ulcer as an atypical manifestation of cutaneous leishmaniasis()()
por: Tironi, Fernanda de Carvalho, et al.
Publicado: (2021)

Clinical Profile and Diagnosis of Recurrent Cutaneous Leishmaniasis
por: Arruda, Sérgio, et al.
Publicado: (2023)

NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis
por: Sacramento, Laís A., et al.
Publicado: (2023)

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
por: Volpedo, Greta, et al.
Publicado: (2021)

Immunomodulation From Moderate Exercise Promotes Control of Experimental Cutaneous Leishmaniasis
por: Terra, Rodrigo, et al.
Publicado: (2019)

Editorial: Cutaneous Leishmaniasis: Exploring Pathogenesis and Immunomodulatory Approaches
por: Pavanelli, Wander Rogério, et al.
Publicado: (2022)

Development of Cutaneous Leishmaniasis after Leishmania Skin Test
por: Machado, Paulo R., et al.
Publicado: (2011)

IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis
por: Gimblet, Ciara, et al.
Publicado: (2015)

Apigenin is a promising molecule for treatment of visceral leishmaniasis
por: Emiliano, Yago S. S., et al.
Publicado: (2023)

Humoral response in Leishmaniasis
por: Conde, Luciana, et al.
Publicado: (2022)

Multiparametric analysis of host and parasite elements in new world tegumentary leishmaniasis
por: de Carvalho, Bruna Caroline, et al.
Publicado: (2022)

Prostaglandin E2 contributes to L. braziliensis survival and therapeutic failure in cutaneous leishmaniasis
por: Nascimento, Maurício T., et al.
Publicado: (2023)

Matrix Metalloproteinase 9 Production by Monocytes is Enhanced by TNF and Participates in the Pathology of Human Cutaneous Leishmaniasis
por: Campos, Taís M., et al.
Publicado: (2014)

Healed Lesions of Human Cutaneous Leishmaniasis Caused By Leishmania major Do Not Shelter Persistent Residual Parasites
por: Sghaier, Rabiaa M., et al.
Publicado: (2022)

Leptomonas seymouri Co-infection in Cutaneous Leishmaniasis Cases Caused by Leishmania donovani From Himachal Pradesh, India
por: Thakur, Lovlesh, et al.
Publicado: (2020)

Unveiling drug-tolerant and persister-like cells in Leishmania braziliensis lines derived from patients with cutaneous leishmaniasis
por: Jara, Marlene, et al.
Publicado: (2023)

The Presence of Leishmania braziliensis DNA in the Nasal Mucosa of Cutaneous Leishmaniasis Patients and the Search for Possible Clinical and Immunological Patterns of Disease Progression: A Cross Sectional Study
por: Barroso, Daniel Holanda, et al.
Publicado: (2021)

Phenotypic and Functional Profiles of Antigen-Specific CD4(+) and CD8(+) T Cells Associated With Infection Control in Patients With Cutaneous Leishmaniasis
por: Egui, Adriana, et al.
Publicado: (2018)

Editorial: Biomarkers in Leishmaniasis
por: Carrillo, Eugenia, et al.
Publicado: (2019)

Histological Disorganization of Spleen Compartments and Severe Visceral Leishmaniasis
por: Hermida, Micely d'El-Rei, et al.
Publicado: (2018)

TREM-1 Expression on the Surface of Neutrophils in Patients With Visceral Leishmaniasis Is Associated With Immunopathogenesis
por: Bomfim, Lays Gisele Santos, et al.
Publicado: (2022)

Leishmania Exosomes/Extracellular Vesicles Containing GP63 Are Essential for Enhance Cutaneous Leishmaniasis Development Upon Co-Inoculation of Leishmania amazonensis and Its Exosomes
por: da Silva Lira Filho, Alonso, et al.
Publicado: (2022)

Some Good and Some Bad: Sand Fly Salivary Proteins in the Control of Leishmaniasis and in Autoimmunity
por: Aoki, Valeria, et al.
Publicado: (2022)

Editorial: Immunology and immunopathogenesis of human leishmaniasis
por: de Menezes, Juliana P. B., et al.
Publicado: (2022)

Unbalanced production of LTB(4)/PGE(2) driven by diabetes increases susceptibility to cutaneous leishmaniasis
por: Bonyek-Silva, Icaro, et al.
Publicado: (2020)

Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America
por: Brodskyn, Claudia I., et al.
Publicado: (2018)

Biomarkers in Post-kala-azar Dermal Leishmaniasis
por: Zijlstra, Eduard E.
Publicado: (2019)

Genetics, Transcriptomics and Meta-Taxonomics in Visceral Leishmaniasis
por: Blackwell, Jenefer M., et al.
Publicado: (2020)

Role of Cytokines in Experimental and Human Visceral Leishmaniasis
por: Samant, Mukesh, et al.
Publicado: (2021)

Transforming Growth Factor Beta (TGFβ1) and Epidermal Growth Factor (EGF) as Biomarkers of Leishmania (V) braziliensis Infection and Early Therapeutic Response in Cutaneous Leishmaniasis: Studies in Hamsters
por: Montoya, Andrés, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7etv94umf2gctvs9b2o5pu682r